SCHEMBL4746067

SCHEMBL4746067

COc1ccc(C2CCN(S(=O)(=O)c3ccc(Sc4cccc(OC)c4)c4nonc34)CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.46
MEN1 O00255 5/20 0.46
THRB P10828 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
RECQL P46063 1/20 0.44
ACLY P53396 1/20 0.42
MAPT P10636 3/20 0.42
ALOX15 P16050 2/20 0.41
USP2 O75604 1/20 0.40
POLB P06746 1/20 0.40
MAPK1 P28482 1/20 0.40
CLK1 P49759 1/20 0.40
TP53 P04637 1/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
USP5 P45974 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8161152 0.94 TP53 (0.45) KMT2AMEN1THRBCYP1A2CYP3A4
SCHEMBL8153861 0.92 ACLY (0.45) KMT2AMEN1THRBCYP1A2CYP3A4
SCHEMBL4746102 0.91 ACLY (0.44) KMT2AMEN1THRBCYP1A2CYP3A4
SCHEMBL4745397 0.86 KMT2A (0.43) KMT2AMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL4742206 0.86 ALDH1A1 (0.43) KMT2AMEN1THRBMAPTPOLB
SCHEMBL4746885 0.85 KMT2A (0.44) KMT2AMEN1THRBCYP1A2CYP3A4
SCHEMBL4784226 0.83 KMT2A (0.46) KMT2AMEN1THRBCYP1A2CYP3A4
SCHEMBL4788023 0.83 TSHR (0.43) KMT2AMEN1THRBCYP1A2CYP3A4
SCHEMBL4743021 0.82 ALDH1A1 (0.42) KMT2AMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL4788418 0.81 THRB (0.47) KMT2AMEN1THRBCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008115259-A2 DERIVATIVES OF BENZOXADIAZOLE SUITABLE FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES RIGEL PHARMACEUTICALS, INC. (US) 2008-09-25 WO claimed